High long non-coding RNA NORAD expression predicts poor prognosis and promotes breast cancer progression by regulating TGF-β pathway
Abstract Background To investigate the expression and significance of long noncoding RNA NORAD (lncRNA-NORAD) in breast cancer. Methods Q-PCR was adopted to detect the mRNA expression of lncRNA-NORAD in breast cancer and adjacent tissues, survival analysis to compare the low-expression groups with t...
Main Authors: | Ke Zhou, Qin Ou, Geng Wang, Wenqi Zhang, Yin Hao, Wenfang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-019-0781-6 |
Similar Items
-
Upregulated lncRNA NORAD can diagnose acute cerebral ischemic stroke patients and predict poor prognosis
by: Dongliang Liu, et al.
Published: (2022-12-01) -
Clinical significance of long non-coding RNA NORAD in rheumatoid arthritis
by: Xueru Zhao, et al.
Published: (2024-01-01) -
PUMILIO, but not RBMX, binding is required for regulation of genomic stability by noncoding RNA NORAD
by: Mahmoud M Elguindy, et al.
Published: (2019-07-01) -
The Potential of NORAD–PUMILIO–<i>RALGAPB</i> Regulatory Axis as a Biomarker in Breast Cancer
by: Cristiane Sato Mara Muller, et al.
Published: (2022-11-01) -
Non-coding RNA Activated by DNA Damage: Review of Its Roles in the Carcinogenesis
by: Soudeh Ghafouri-Fard, et al.
Published: (2021-08-01)